
UK offensive security consultancy delivering CREST-accredited penetration testing, adversary simulation and CBEST, TIBER-EU and TBEST threat-led testing, mainly for financial services and other large organisations.
Healthcare organisations are among the most targeted sectors for cyberattacks, with medical records being the most valuable data type on the black market. Hospitals, clinics, health systems, pharmaceutical companies, medical device manufacturers, and health technology providers face threats ranging from ransomware attacks that disrupt patient care to targeted data theft of protected health information (PHI).
Penetration testing in healthcare must address the unique challenges of clinical environments including connected medical devices, electronic health record (EHR) systems, patient portals, telehealth platforms, and integration with insurance and pharmacy systems. Testing must be carefully coordinated to avoid disrupting clinical operations and patient care.
Healthcare pen testing supports compliance with HIPAA, which requires risk analysis and security evaluation of systems handling ePHI. The growing adoption of IoT medical devices, cloud-based EHR systems, and telehealth platforms has expanded the attack surface significantly, making regular security testing essential for patient safety and regulatory compliance.

UK offensive security consultancy delivering CREST-accredited penetration testing, adversary simulation and CBEST, TIBER-EU and TBEST threat-led testing, mainly for financial services and other large organisations.

Penetration testing firm trusted by nine of the top ten US banks, with the Resolve platform for continuous attack surface management.

Global enterprise cybersecurity consultancy founded in 1999 in Oxford, holding rare CREST STAR-FS accreditation and delivering penetration testing, red and purple teaming, and PCI QSA services across five international offices.

Global Big Four professional services firm delivering CREST, CHECK, and CBEST-accredited penetration testing and red teaming services from London, serving the UK's largest enterprises and regulated organisations.
CREST and CHECK-accredited UK penetration testing and managed security provider formed in 2026 from Pentest People, Bulletproof, and Target Defense, with CREST STAR/TLPT-FS capability and the GuardNest vulnerability management platform.
US penetration testing firm founded in 2011, running 600+ engagements a year with a fully remote, US-based team. Manual, expert-led testing across web, network, cloud, mobile, wireless, OT/ICS, and AI/LLM. Gartner Sample Vendor for PTaaS.

Full-service London-based cybersecurity consultancy with CREST, CHECK, and NCSC accreditations delivering offensive testing, managed detection, and strategic advisory services.

Global managed security provider with the elite SpiderLabs penetration testing team and deep PCI DSS compliance expertise.

Manchester-based independent cybersecurity consultancy with over 20 years of experience delivering CREST and CHECK-accredited penetration testing, red teaming, and compliance certification services.

CREST and CHECK-accredited UK penetration testing consultancy with CBEST approval, specialising in infrastructure, application, and simulated attack assessments across the public and private sectors.

CHECK and CREST-accredited Birmingham-based cyber security consultancy with over 15 years of experience delivering penetration testing, red teaming, and OT security assessments for government and private sector clients.

Fast-growing CREST and CHECK-accredited UK cybersecurity consultancy with deep expertise in critical national infrastructure sectors.
Healthcare pen testing must account for patient safety, clinical workflows, connected medical devices, and ePHI protection requirements. Testing must be carefully coordinated to avoid disrupting patient care.
Yes, medical device pen testing is a growing speciality. Testing covers the device itself, its network communications, companion apps, cloud backends, and update mechanisms. Testing must follow FDA guidance and device safety protocols.
Key risks include unauthorised access to patient records, medical device compromises, prescription system manipulation, lateral movement from clinical networks to administrative systems, and ransomware exposure.